New Frontier Health (NFH) 6-K New Frontier Health Corporation Announces First Quarter 2020 Financial Results

FORM 6-K

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549  

Report of Foreign Private Issuer 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934 

For the month of May, 2020

Commission File Number: 001-38562

NEW FRONTIER HEALTH CORPORATION 
(Translation of Registrant’s Name into English)

10 Jiuxianqiao Road,
Hengtong Business Park
B7 Building, 1/F
Chaoyang District, 100015,
Beijing, China
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F:

Form 20-Fx Form 40-F¨

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes¨ Nox

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes¨ Nox

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

Attached as Exhibits 99.1 and 99.2 hereto are the earnings release issued by New Frontier Health Corporation (the “Company”) announcing its financial results for the first quarter ended March 31, 2020, and associated investor presentation, respectively.

EXHIBIT INDEX

Exhibit	Description of Exhibit
99.1	Earnings Release.
99.2	Investor Presentation.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

New Frontier Health Corporation
By:	/s/ Roberta Lipson
	Name: Roberta Lipson
	Title: Chief Executive Officer

Date: May 27, 2020